Literature DB >> 18683033

Engineered Alt a 13 fragment of Alternaria alternata abrogated IgE binding without affecting T-cell stimulation.

Jay Shankar1, Bhanu P Singh, Shailendra N Gaur, Naveen Arora.   

Abstract

RATIONALE: Epitopes were delineated for allergenic proteins, but studies are required to identify residues mediating IgE binding. In the present study, the in silico approach was used to identify IgE-binding residues of Alt a 13(1-50) fragment and confirmed by experimental approach. METHOD AND
RESULTS: IgE-binding epitopes of Alt a 13 mapped computationally were cloned, expressed, purified, and characterized using various immunochemical and biophysical methods. Among four fragments of Alt a 13, Alt a 13(1-50) demonstrated maximum IgE binding with two immunodominant regions and was mutated at these regions. The mutation in first region, Alt a 13(1-50)-K4A_S6F, did not show any change in immunological and biophysical properties of protein. However, mutations in the second region, Alt a 13(1-50)-T21F_N27I, caused reduced IgE binding, histamine release, and low IL-4 release on stimulation of Alternaria alternata positive patients peripheral blood mononuclear cells in vitro.
CONCLUSION: This suggests that residues T21 and N27 are important for the secondary structure. In conclusion, Alt a 13(1-50)-T21F_N27I with reduced Th 2 response and intact T-cell proliferation capacity has potential for clinical use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18683033     DOI: 10.1007/s10875-008-9224-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

1.  Recombinant glutathione-S-transferase a major allergen from Alternaria alternata for clinical use in allergy patients.

Authors:  Jay Shankar; Bhanu P Singh; Shailendra N Gaur; Naveen Arora
Journal:  Mol Immunol       Date:  2006-01-23       Impact factor: 4.407

2.  Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2.

Authors:  J S Stanley; N King; A W Burks; S K Huang; H Sampson; G Cockrell; R M Helm; C M West; G A Bannon
Journal:  Arch Biochem Biophys       Date:  1997-06-15       Impact factor: 4.013

3.  Human IgE-binding epitopes of the latex allergen Hev b 5.

Authors:  D H Beezhold; V L Hickey; J E Slater; G L Sussman
Journal:  J Allergy Clin Immunol       Date:  1999-06       Impact factor: 10.793

4.  Discontinuous IgE-binding epitopes contain multiple continuous epitope regions: results of an epitope mapping on recombinant Hol l 5, a major allergen from velvet grass pollen.

Authors:  G Schramm; A Bufe; A Petersen; H Haas; R Merget; M Schlaak; W M Becker
Journal:  Clin Exp Allergy       Date:  2001-02       Impact factor: 5.018

5.  Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1.

Authors:  S Lebecque; C Dolecek; S Laffer; V Visco; S Denépoux; J J Pin; C Guret; G Boltz-Nitulescu; A Weyer; R Valenta
Journal:  J Allergy Clin Immunol       Date:  1997-03       Impact factor: 10.793

Review 6.  Fungal allergies: a yet unsolved problem.

Authors:  Reto Crameri; Michael Weichel; Sabine Flückiger; Andreas G Glaser; Claudio Rhyner
Journal:  Chem Immunol Allergy       Date:  2006

7.  Vaccination with genetically engineered allergens prevents progression of allergic disease.

Authors:  V Niederberger; F Horak; S Vrtala; S Spitzauer; M-T Krauth; P Valent; J Reisinger; M Pelzmann; B Hayek; M Kronqvist; G Gafvelin; H Grönlund; A Purohit; R Suck; H Fiebig; O Cromwell; G Pauli; M van Hage-Hamsten; R Valenta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

Review 8.  Recombinant allergens for diagnosis and immunotherapy of allergic disorders, with emphasis on cockroach allergy.

Authors:  Kyoung Yong Jeong; Chein-Soo Hongb; Tai-Soon Yong
Journal:  Curr Protein Pept Sci       Date:  2006-02       Impact factor: 3.272

9.  Ole e I: epitope mapping, cross-reactivity with other Oleaceae pollens and ultrastructural localization.

Authors:  E Martín-Orozco; B Cárdaba; V del Pozo; B de Andrés; M Villalba; S Gallardo; M I Rodriguez-García; M C Fernández; J D Alché; R Rodriguez
Journal:  Int Arch Allergy Immunol       Date:  1994       Impact factor: 2.749

10.  Alternaria alternata NADP-dependent mannitol dehydrogenase is an important fungal allergen.

Authors:  P B Schneider; U Denk; M Breitenbach; K Richter; P Schmid-Grendelmeier; S Nobbe; M Himly; A Mari; C Ebner; B Simon-Nobbe
Journal:  Clin Exp Allergy       Date:  2006-12       Impact factor: 5.018

View more
  4 in total

1.  Characterization of recombinant per a 10 from Periplaneta americana.

Authors:  Dhanapal Govindaraj; Shailendra Nath Gaur; Naveen Arora
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

Review 2.  Mold allergens in respiratory allergy: from structure to therapy.

Authors:  Teresa E Twaroch; Mirela Curin; Rudolf Valenta; Ines Swoboda
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-11       Impact factor: 5.764

Review 3.  Alternaria alternata and its allergens: a comprehensive review.

Authors:  Irena Kustrzeba-Wójcicka; Emilia Siwak; Grzegorz Terlecki; Anna Wolańczyk-Mędrala; Wojciech Mędrala
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

4.  Preclinical safety and immunological efficacy of Alternaria alternata polymerized extracts.

Authors:  María Morales; María T Gallego; Victor Iraola; Raquel Moya; Soraya Santana; Jerónimo Carnés
Journal:  Immun Inflamm Dis       Date:  2017-12-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.